These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 24008512)
1. Y-39983, a selective Rho-kinase inhibitor, attenuates experimental autoimmune encephalomyelitis via inhibition of demyelination. Gao C; Huang L; Long Y; Zheng J; Yang J; Pu S; Xie L Neuroimmunomodulation; 2013; 20(6):334-40. PubMed ID: 24008512 [TBL] [Abstract][Full Text] [Related]
2. Protective effect of a novel Rho kinase inhibitor WAR-5 in experimental autoimmune encephalomyelitis by modulating inflammatory response and neurotrophic factors. Li YH; Yu JZ; Xin YL; Feng L; Chai Z; Liu JC; Zhang HZ; Zhang GX; Xiao BG; Ma CG Exp Mol Pathol; 2015 Oct; 99(2):220-8. PubMed ID: 26112093 [TBL] [Abstract][Full Text] [Related]
3. Estrogen inhibits estrogen receptor α-mediated rho-kinase expression in experimental autoimmune encephalomyelitis rats. Feng J; Zhang G; Hu X; Si Chen C; Qin X Synapse; 2013 Jul; 67(7):399-406. PubMed ID: 23401288 [TBL] [Abstract][Full Text] [Related]
4. Organized migration of epithelial cells requires control of adhesion and protrusion through Rho kinase effectors. Hopkins AM; Pineda AA; Winfree LM; Brown GT; Laukoetter MG; Nusrat A Am J Physiol Gastrointest Liver Physiol; 2007 Mar; 292(3):G806-17. PubMed ID: 17138966 [TBL] [Abstract][Full Text] [Related]
5. Lentivirus-mediated estrogen receptor α overexpression in the central nervous system ameliorates experimental autoimmune encephalomyelitis in mice. Hu X; Qin X Int J Mol Med; 2013 May; 31(5):1209-21. PubMed ID: 23525227 [TBL] [Abstract][Full Text] [Related]
6. Involvement of neuropsin in the pathogenesis of experimental autoimmune encephalomyelitis. Terayama R; Bando Y; Yamada M; Yoshida S Glia; 2005 Nov; 52(2):108-18. PubMed ID: 15920728 [TBL] [Abstract][Full Text] [Related]
7. Role of Rho Kinase and Fasudil on Synaptic Plasticity in Multiple Sclerosis. Chen C; Yu JZ; Zhang Q; Zhao YF; Liu CY; Li YH; Yang WF; Ma CG; Xiao BG Neuromolecular Med; 2015 Dec; 17(4):454-65. PubMed ID: 26481340 [TBL] [Abstract][Full Text] [Related]
8. Axonal loss and gray matter pathology as a direct result of autoimmunity to neurofilaments. Huizinga R; Gerritsen W; Heijmans N; Amor S Neurobiol Dis; 2008 Dec; 32(3):461-70. PubMed ID: 18804534 [TBL] [Abstract][Full Text] [Related]
9. Distinct pathological patterns in relapsing-remitting and chronic models of experimental autoimmune enchephalomyelitis and the neuroprotective effect of glatiramer acetate. Aharoni R; Vainshtein A; Stock A; Eilam R; From R; Shinder V; Arnon R J Autoimmun; 2011 Nov; 37(3):228-41. PubMed ID: 21752599 [TBL] [Abstract][Full Text] [Related]
10. Cerebral cortex demyelination and oligodendrocyte precursor response to experimental autoimmune encephalomyelitis. Girolamo F; Ferrara G; Strippoli M; Rizzi M; Errede M; Trojano M; Perris R; Roncali L; Svelto M; Mennini T; Virgintino D Neurobiol Dis; 2011 Sep; 43(3):678-89. PubMed ID: 21679768 [TBL] [Abstract][Full Text] [Related]
11. Modulation of aqueous humor outflow facility by the Rho kinase-specific inhibitor Y-27632. Rao PV; Deng PF; Kumar J; Epstein DL Invest Ophthalmol Vis Sci; 2001 Apr; 42(5):1029-37. PubMed ID: 11274082 [TBL] [Abstract][Full Text] [Related]
12. Adenosine-oligoarginine conjugate, a novel bisubstrate inhibitor, effectively dissociates the actin cytoskeleton. Räägel H; Lust M; Uri A; Pooga M FEBS J; 2008 Jul; 275(14):3608-24. PubMed ID: 18540886 [TBL] [Abstract][Full Text] [Related]
13. Therapeutic potentials of the Rho kinase inhibitor Fasudil in experimental autoimmune encephalomyelitis and the related mechanisms. Yan Y; Yu J; Gao Y; Kumar G; Guo M; Zhao Y; Fang Q; Zhang H; Yu J; Jiang Y; Zhang HT; Ma CG Metab Brain Dis; 2019 Apr; 34(2):377-384. PubMed ID: 30552558 [TBL] [Abstract][Full Text] [Related]
14. Multiple sclerosis and chronic autoimmune encephalomyelitis: a comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions. Kornek B; Storch MK; Weissert R; Wallstroem E; Stefferl A; Olsson T; Linington C; Schmidbauer M; Lassmann H Am J Pathol; 2000 Jul; 157(1):267-76. PubMed ID: 10880396 [TBL] [Abstract][Full Text] [Related]
15. Molecular characterization of the effects of Y-27632. Darenfed H; Dayanandan B; Zhang T; Hsieh SH; Fournier AE; Mandato CA Cell Motil Cytoskeleton; 2007 Feb; 64(2):97-109. PubMed ID: 17009325 [TBL] [Abstract][Full Text] [Related]
16. [Features of pathological changes in the non-myelin sheath of rats with experimental autoimmune encephalomyelitis]. Zhang JF; Huang R; Yang YJ; Xu J; Jin SJ Zhongguo Dang Dai Er Ke Za Zhi; 2012 Apr; 14(4):306-9. PubMed ID: 22537964 [TBL] [Abstract][Full Text] [Related]
17. Pattern of axonal injury in murine myelin oligodendrocyte glycoprotein induced experimental autoimmune encephalomyelitis: implications for multiple sclerosis. Herrero-Herranz E; Pardo LA; Gold R; Linker RA Neurobiol Dis; 2008 May; 30(2):162-73. PubMed ID: 18342527 [TBL] [Abstract][Full Text] [Related]
18. Transient axonal injury in the absence of demyelination: a correlate of clinical disease in acute experimental autoimmune encephalomyelitis. Aboul-Enein F; Weiser P; Höftberger R; Lassmann H; Bradl M Acta Neuropathol; 2006 Jun; 111(6):539-47. PubMed ID: 16718350 [TBL] [Abstract][Full Text] [Related]
19. Axon loss is responsible for chronic neurological deficit following inflammatory demyelination in the rat. Papadopoulos D; Pham-Dinh D; Reynolds R Exp Neurol; 2006 Feb; 197(2):373-85. PubMed ID: 16337942 [TBL] [Abstract][Full Text] [Related]
20. Pathological findings in rats with experimental allergic encephalomyelitis. Dong M; Liu R; Guo L; Li C; Tan G APMIS; 2008 Nov; 116(11):972-84. PubMed ID: 19132994 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]